Patent details

Basic Information

Publication number:

EP3006023

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151926474

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SORBIC ACID AND DERIVATIVES THEREOF TO ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL

French Title of Invention:

ACIDE SORBIQUE ET DÉRIVÉS DE CELUI-CI POUR AMÉLIORER L'ACTION D'UN PRODUIT NEUROPHARMACEUTIQUE

German Title of Invention:

SORBINSÄURE UND DERIVATE DAVON ZUR VERSTÄRKUNG DER WIRKUNG EINES NEUROPHARMAKONS

SPC Number:

Dates

Filing date:

19/01/2010

Grant date:

26/06/2019

EP Publication Date:

13/04/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/06/2019

EP B1 Publication Date:

26/06/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/01/2020

Expiration date:

19/01/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/06/2019

 

 

Name:

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

Address:

1124 West Carson Street, Torrance, CA 90250-2064, United States (US)

Inventor

Name:

Tsai, Guochuan Emil

Address:

United States (US)

Priority

Priority Number:

145931 P

Priority Date:

20/01/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/19; A61K 45/06; A61P 25/00;

Publication

European Patent Bulletin

Issue number:

201926

Publication date:

26/06/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages